A new drug to treat alcoholism has improved the chances of addicts quitting drinking, the director of Japan’s largest alcoholism treatment center says.

Regtect, which went on sale in May, is sold by Nippon Shinyaku Co., which licensed it from Merck Sante of France.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.